| Literature DB >> 34895353 |
Takuaki Tani1,2, Shinobu Imai3,4, Kiyohide Fushimi5,3.
Abstract
BACKGROUND: Appropriate treatment of stroke immediately after its onset contributes to the improved chances, while delay in hospitalisation affects stroke severity and fatality. This study aimed to determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on emergency hospitalisation of patients with stroke in Japan.Entities:
Keywords: COVID-19; Emergency admission; Stroke; Time series
Year: 2021 PMID: 34895353 PMCID: PMC8666267 DOI: 10.1186/s42466-021-00163-8
Source DB: PubMed Journal: Neurol Res Pract ISSN: 2524-3489
Fig. 1Flowchart of the study cohort
Baseline characteristics of patients with stroke
| Variables | Pre-COVID-19 period | COVID-19 period | SMD | |
|---|---|---|---|---|
| n | 19,709 | 16,975 | ||
| Age, N, % | 0.021 | 0.649 | ||
| 0–44 | 308 (1.6) | 242 (1.5) | ||
| 45–54 | 916 (4.6) | 752 (4.4) | ||
| 55–64 | 1790 (9.1) | 1508 (8.9) | ||
| 65–74 | 4693 (23.8) | 3986 (23.5) | ||
| 75–84 | 6702 (34.0) | 5846 (34.4) | ||
| 85- | 5300 (26.9) | 4641 (27.3) | ||
| Sex (Female), N, % | 8395 (42.6) | 7234 (42.6) | < 0.001 | 0.976 |
| BMI, N, % | 0.046 | 0.002 | ||
| < 18.5 | 2264 (11.7) | 1964 (11.7) | ||
| 18.5–24.9 | 11,111 (57.2) | 9521 (56.8) | ||
| 25–29 | 3704 (19.1) | 3403 (20.3) | ||
| 30–34 | 679 (3.5) | 547 (3.3) | ||
| 35 and over | 693 (3.6) | 600 (3.6) | ||
| NA | 970 (5.0) | 714 (4.3) | ||
| mRS at admission, N, % | 0.028 | 0.324 | ||
| 0 | 8658 (44.1) | 7458 (44.0) | ||
| 1 | 3650 (18.6) | 3073 (18.1) | ||
| 2 | 2451 (12.5) | 2186 (12.9) | ||
| 3 | 1896 (9.6) | 1704 (10.1) | ||
| 4 | 1936 (9.9) | 1674 (9.9) | ||
| 5 | 842 (4.3) | 663 (3.9) | ||
| Other | 221 (1.1) | 185 (1.1) | ||
| CCI, N, % | 0.014 | 0.618 | ||
| 0 | 16,717 (84.8) | 14,362 (84.6) | ||
| 1 | 2538 (12.9) | 2191 (12.9) | ||
| 2 | 399 (2.0) | 377 (2.2) | ||
| 3 | 55 (0.3) | 45 (0.3) | ||
| Admission pathway, N, % | 0.049 | 0.002 | ||
| Home | 16,315 (82.8) | 14,103 (83.1) | ||
| Facility | 1456 (7.4) | 1323 (7.8) | ||
| Transfer | 1917 (9.7) | 1524 (9.0) | ||
| Else | 21 (0.1) | 25 (0.1) | ||
| Stroke of onset time, N, % | 0.052 | < 0.001 | ||
| 3 days or less | 16,629 (84.6) | 14,438 (85.2) | ||
| 4–7 days | 928 (4.7) | 861 (5.1) | ||
| 8 days or more | 1796 (9.1) | 1471 (8.7) | ||
| Asymptomatic | 302 (1.5) | 172 (1.0) | ||
| Ambulance, N, % | 9950 (50.5) | 8853 (52.2) | 0.033 | 0.002 |
BMI body mass index, JCS Japan Coma Scale, BI Barthel Index, CCI Carlson Comorbidity Index, SMD standardised mean difference
Mean JCS score, LOS, fatalities, fatalities in 24 h, mRS, and discharge during the COVID-19 pandemic period
| Variables | Pre-COVID-19 period | COVID-19 period | Diff | SMD | |||
|---|---|---|---|---|---|---|---|
| SCU | 2433 | (12.3) | 2153 | (12.7) | 0.4 | 0.01 | 0.336 |
| IVT, N, % | 1125 | (5.7) | 1096 | (6.5) | 0.8 | 0.031 | 0.003 |
| MT, N, % | 868 | (4.4) | 807 | (4.8) | 0.4 | 0.017 | 0.115 |
| JCS at admission, N, % | 0.071 | < 0.001 | |||||
| 0 | 9813 | (49.8) | 7896 | (46.5) | − 0.33 | ||
| 1 | 7540 | (38.3) | 6897 | (40.6) | 2.3 | ||
| 2 | 1621 | (8.2) | 1425 | (8.4) | 0.2 | ||
| 3 | 735 | (3.7) | 757 | (4.5) | 0.8 | ||
| LOS, Mean, SD | 31.32 | (34.59) | 28.01 | (27.0) | − 3.31 | 0.107 | < 0.001 |
| Fatalities, N, % | 1070 | (5.4) | 878 | (5.2) | − 0.2 | 0.011 | 0.285 |
| Fatalities in 24 h, N, % | 37 | (0.2) | 66 | (0.4) | 0.2 | 0.038 | < 0.001 |
| mRS at discharge, N, % | 0.041 | 0.03 | |||||
| 0 | 1970 | (10.0) | 1559 | (9.2) | − 0.8 | ||
| 1 | 4310 | (21.9) | 3679 | (21.7) | − 0.2 | ||
| 2 | 3493 | (17.8) | 3111 | (18.4) | 0.6 | ||
| 3 | 2720 | (13.8) | 2294 | (13.6) | − 0.2 | ||
| 4 | 3886 | (19.8) | 3381 | (20.0) | 0.2 | ||
| 5 | 2163 | (11.0) | 1997 | (11.8) | 0.8 | ||
| Other | 1100 | (5.6) | 901 | (5.3) | − 0.3 | ||
| Discharge destination, N, % | 0.038 | 0.004 | |||||
| Home | 10,666 | (54.1) | 9050 | (53.3) | − 0.8 | ||
| Facility | 1706 | (8.7) | 1375 | (8.1) | − 0.6 | ||
| Hospital | 6252 | (31.7) | 5661 | (33.3) | 1.6 | ||
| Other | 1085 | (5.5) | 889 | (5.2) | − 0.3 | ||
SCU Stroke care unit, IVT intravenous thrombolysis, MT Mechanical thrombectomy, LOS length of hospital stay, JCS Japan Coma Scale, mRS modified Ranking Scale
Interrupted time series analysis for the number of patients with stroke from April 2018″ to 31 August 2020
| Change in level | Change in slope | |||||
|---|---|---|---|---|---|---|
| RR | 95% CI | RR | 95% CI | |||
| Hospital admissions | 0.97 | (0.90, 1.06) | 0.5 | 0.97 | (0.95, 0.99) | 0.027 |
| JCS0 | 0.95 | (0.92, 0.98) | < 0.001*** | 1.00 | (0.99, 1.00) | 0.3 |
| JCS1 | 1.04 | (1.01, 1.07) | 0.023* | 1.01 | (1.00, 1.02) | 0.3 |
| JCS2 | 1.02 | (0.96, 1.09) | 0.5 | 0.99 | (0.97, 1.01) | 0.5 |
| JCS3 | 1.24 | (1.14, 1.36) | < 0.001*** | 1.01 | (0.99, 1.04) | 0.3 |
| Fatalities within 24 h | 1.75 | (1.29, 2.33) | < 0.001*** | 1.15 | (1.04, 1.27) | 0.004** |
| Fatalities | 0.96 | (0.80, 1.13) | 0.6 | 0.93 | (0.88, 0.98) | 0.017* |
| SCU | 1.00 | (0.95, 1.05) | 0.9 | 1.06 | (1.04, 1.08) | < 0.001*** |
| IVT | 0.96 | (0.88, 1.05) | 0.4 | 1.00 | (0.97, 1.03) | 0.9 |
| MT, N, % | 1.02 | (0.94, 0.95) | 0.5 | 1.00 | (0.98, 1.02) | 0.9 |
RR risk ratio, CI confidence interval, JCS Japan Coma Scale, SCU Stroke care unit, IVT intravenous thrombolysis, MT Mechanical thrombectomy
***P < 0.001, **P < 0.01, *P < 0.05
Fig. 2Interrupted time series analysis of emergency stroke admissions in the COVID-19 pandemic